MedTrace Logo

Evaluation of Liver Fibrosis in HIV-infected Patients With Metabolic Syndrome

NCT02353767 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 478

Last updated 2015-02-03

No results posted yet for this study

Summary

This study aims to estimate the prevalence of bridging liver fibrosis and cirrhosis (METAVIR score ≥ F2) according to METAVIR score in HIV infected patients not chronically infected by viral hepatitis but exhibiting a metabolic syndrome according to the IDF definition (International Diabetes Foundation).

Conditions

  • Abdominal Obesity Metabolic Syndrome
  • HIV
  • Liver Fibrosis

Interventions

PROCEDURE

Noninvasive evaluation of liver fibrosis and steatosis

Transient elastography (using the Fibroscan, CAP Fibroscan) and biomarker panels (FibroTest, Fibromètre, Hepascore, Steatotest, Nashtest)

Sponsors & Collaborators

  • Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-02-28
Completion
2013-02-28

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02353767 on ClinicalTrials.gov